MA30328B1 - Nouvelles formulations - Google Patents

Nouvelles formulations

Info

Publication number
MA30328B1
MA30328B1 MA31274A MA31274A MA30328B1 MA 30328 B1 MA30328 B1 MA 30328B1 MA 31274 A MA31274 A MA 31274A MA 31274 A MA31274 A MA 31274A MA 30328 B1 MA30328 B1 MA 30328B1
Authority
MA
Morocco
Prior art keywords
formulations
new formulations
fpf
variability
therapy
Prior art date
Application number
MA31274A
Other languages
English (en)
Inventor
John Capecchi
James Stefely
Trevor Riley
Original Assignee
Glaxo Group Ltd
3M Innovative Properties Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38523271&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA30328(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Glaxo Group Ltd, 3M Innovative Properties Co filed Critical Glaxo Group Ltd
Publication of MA30328B1 publication Critical patent/MA30328B1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
    • A61L2/23—Solid substances, e.g. granules, powders, blocks, tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La présente invention concerne de nouvelles formulations d'aérosols médicamenteux, des procédés de préparation desdites formulations, leur utilisation en thérapie, des inhalateurs-doseurs contenant lesdites formulations et l'utilisation de polymères biocompatibles pour réduire la variabilité de l'uniformité de teneur et/ou pour obtenir une meilleure fraction de particules fines (FPF) dans lesdites formulations.
MA31274A 2006-03-22 2008-10-07 Nouvelles formulations MA30328B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US78463406P 2006-03-22 2006-03-22

Publications (1)

Publication Number Publication Date
MA30328B1 true MA30328B1 (fr) 2009-04-01

Family

ID=38523271

Family Applications (1)

Application Number Title Priority Date Filing Date
MA31274A MA30328B1 (fr) 2006-03-22 2008-10-07 Nouvelles formulations

Country Status (18)

Country Link
EP (1) EP2012797A2 (fr)
JP (1) JP2009530419A (fr)
KR (1) KR20080110854A (fr)
CN (1) CN101415428A (fr)
AR (1) AR060039A1 (fr)
AU (1) AU2007226899A1 (fr)
BR (1) BRPI0708798A2 (fr)
CA (1) CA2646236A1 (fr)
CR (1) CR10261A (fr)
EA (1) EA200801854A1 (fr)
IL (1) IL193723A0 (fr)
MA (1) MA30328B1 (fr)
MX (1) MX2008011967A (fr)
NO (1) NO20083760L (fr)
PE (1) PE20080124A1 (fr)
TW (1) TW200803870A (fr)
WO (1) WO2007109698A2 (fr)
ZA (1) ZA200807682B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT3578169T (pt) * 2009-02-26 2024-07-29 Glaxo Group Ltd Formulações farmacêuticas compreendendo 4-{(1r)-2-[(2,6- diclorobenzil)oxi]etoxi}hexil)amino]-1-hidroxietil}-2- (hidroximetil)fenol
GB0921075D0 (en) 2009-12-01 2010-01-13 Glaxo Group Ltd Novel combination of the therapeutic agents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU679511B2 (en) * 1993-03-17 1997-07-03 Minnesota Mining And Manufacturing Company Aerosol formulation containing an ester-, amide-, or mercaptoester-derived dispersing aid
US6750210B2 (en) * 2000-08-05 2004-06-15 Smithkline Beecham Corporation Formulation containing novel anti-inflammatory androstane derivative
BRPI0113042B8 (pt) * 2000-08-05 2021-05-25 Glaxo Group Ltd composto da fórmula ou um seu solvato fisiologicamente aceitável, uso do mesmo, composição farmacêutica, formulação farmacêutica, método para o tratamento de um indivíduo humano ou animal com uma condição inflamatória e/ou alérgica, e, processo para preparar um composto ou um seu solvato

Also Published As

Publication number Publication date
ZA200807682B (en) 2009-11-25
CA2646236A1 (fr) 2007-09-27
PE20080124A1 (es) 2008-04-21
EA200801854A1 (ru) 2009-04-28
EP2012797A2 (fr) 2009-01-14
JP2009530419A (ja) 2009-08-27
CR10261A (es) 2008-11-26
TW200803870A (en) 2008-01-16
WO2007109698A2 (fr) 2007-09-27
NO20083760L (no) 2008-12-17
BRPI0708798A2 (pt) 2011-06-14
IL193723A0 (en) 2009-08-03
WO2007109698A3 (fr) 2008-12-18
AU2007226899A1 (en) 2007-09-27
CN101415428A (zh) 2009-04-22
AR060039A1 (es) 2008-05-21
KR20080110854A (ko) 2008-12-19
MX2008011967A (es) 2009-01-14

Similar Documents

Publication Publication Date Title
PT1173244E (pt) Inalador de po para um medicamento combinado
DK1173243T3 (da) Pulverinhalator til kombineret medikament
MA33608B1 (fr) Composition pharmaceutique, forme galenique, procede pour leur preparation, methodes de traitement et leurs utilisations
SG166093A1 (en) Inhibitors of brutonæs tyrosine kinase
SG167657A1 (en) Novel medicament compositions based on tiotropium salts and on salmeterol salts
EA017764B8 (ru) Фармацевтическая композиция, способ ее получения и способ лечения вирусных заболеваний с ее использованием
WO2005070965A3 (fr) Compositions pharmaceutiques contenant des antagonistes a lrp4, lrp8 ou a la megaline pour le traitement de maladies
TW200731975A (en) Novel combinations of medicaments for the treatment of respiratory diseases
MA31941B1 (fr) Bis-pyridylpyridones en tant qu'antagonistes du récepteur 1 de l'hormone de concentration de la mélanine
MA35455B1 (fr) (wo2013045407) dérivés d'estra-1,3,5(10),16-tétraène-3-carboxamide, procédé pour leur fabrication, préparations pharmaceutiques contenant ces substances ainsi que leur utilisation dans la fabrication de médicaments
UA104988C2 (uk) Похідні піроніндолу та спосіб їх отримання
EA200802350A3 (ru) Система доставки лекарств
MY146802A (en) Novel drugs for treating respiratory diseases
GB2446341A (en) Method and system for transdermal drug delivery
MA30328B1 (fr) Nouvelles formulations
WO2005002551A3 (fr) Inhibiteurs de recepteur vanilloide pour le traitement d'etats de douleurs provoques par le virus de l'immunodeficience humaine (vih)
EA200500387A1 (ru) Композиции для ингаляции с высоким содержанием лекарственных веществ
Hodgson et al. Saunders Nursing Drug Handbook 2013
TW200509985A (en) Drug delivery system for sub-Tenon administration of fine particles
MA55425A1 (fr) Compositions solides orales à libération immédiate à unités multiples, procédés et utilisations de celles-ci
UA86600C2 (ru) Лекарственная композиция для ингаляции, которая содержит микрочастицы двух противотуберкулезных препаратов и способный биологически раскладываться полимер, способ изготовления композиции